| For: | Han HF, Liu SZ, Zhang X, Wei M, Huang X, Yu WB. Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats. World J Gastroenterol 2022; 28(31): 4338-4350 [PMID: 36159018 DOI: 10.3748/wjg.v28.i31.4338] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i31/4338.htm |
| Number | Citing Articles |
| 1 |
Dhiraj Kumar Sah, Archana Arjunan, Sun Young Park, Young Do Jung. Bile acids and microbes in metabolic disease. World Journal of Gastroenterology 2022; 28(48): 6846-6866 doi: 10.3748/wjg.v28.i48.6846
|
| 2 |
Weimin Zhou, Jing Qiu, Meng Peng, Yuting Liu, Chunguang Qiu, Liang Pan. Methyl rosmarinate alleviates myocardial ischemia–reperfusion injury in mice via triggering TGR5/AMPK signaling axis. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04703-w
|
| 3 |
Rulin Wang, Zhaxi Dunzhu, Zhixin Tan, Zhendong Niu, Haowen Tan, Yongli Gao, Yu Cao. Development and validation of an interpretable machine learning model for early prediction in patients with diabetes and sepsis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-22488-z
|
| 4 |
Anna Maria Dąbrowska, Jarosław Dudka. Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders. Drug Discovery Today 2025; 30(6): 104386 doi: 10.1016/j.drudis.2025.104386
|
| 5 |
Mengting Ren, Yi Xia, Hanghai Pan, Xinxin Zhou, Mosang Yu, Feng Ji. Duodenal-jejunal bypass ameliorates MASLD in rats by regulating gut microbiota and bile acid metabolism through FXR pathways. Hepatology Communications 2025; 9(2) doi: 10.1097/HC9.0000000000000615
|
